Oragenics, Inc. (OGEN) vs Propanc Biopharma Inc (PPCB)

Oragenics, Inc. and Propanc Biopharma Inc are both Biotechnology companies. Oragenics, Inc. and Propanc Biopharma Inc are of similar size ($2.3M and $2.1M). Propanc Biopharma Inc trades at the lower P/E: 0.0× against 0.4×. Across the 11 metrics below, Propanc Biopharma Inc leads on 7 and Oragenics, Inc. on 4.

Valuation

Metric OGEN PPCB Biotechnology median
P/E 0.44 0.00 7.88
P/S 17.54 n/m 11.47
P/B 0.59 0.06 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.16 n/m 0.74
EV/Sales (13.16) n/m 10.73
Earnings yield 228.10% 257,474.29% (28.84%)
Free cash flow yield (469.27%) (739.21%) (23.03%)

Profitability

Metric OGEN PPCB Biotechnology median
Gross margin 19.89% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (1,307.07%) (138.20%) (57.72%)
Return on assets (264.23%) (104.68%) (49.22%)
Return on invested capital 0.00% (116.59%) 0.00%

Growth

Metric OGEN PPCB Biotechnology median
Revenue growth (TTM) (75.08%) — 5.64%
EPS growth (last fiscal year) 90.51% 98.81% —
Revenue growth, 5-year CAGR (50.98%) — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric OGEN PPCB Biotechnology median
Debt to equity 0.00 0.05 0.00
Current ratio 3.01 2.37 4.73
Net debt to EBITDA 0.98 (0.01) 0.96

Dividend

Metric OGEN PPCB Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 — 0.00

Size

Metric OGEN PPCB Biotechnology median
Market cap 2.27m 2.14m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack